News

October 26, 2020October 27, 2020

Adding Ibrance to Hormone Therapy Fails to Prolong Time Before Cancer Recurs, Trial Shows

News

Adding Ibrance (palbociclib) to standard endocrine therapy failed to prolong the time women with early hormone receptor (HR)-positive, human epidermal growth factor (HER2)-negative breast cancer lived without having their disease ... Read more

October 22, 2020October 22, 2020

COVID-19 Surgery Delays May Mean 2,700 More Breast Cancer Deaths Within 10 Years

News

Delays in breast cancer surgery due to the COVID-19 pandemic could cost 2,797 additional deaths in the U.S. over the next decade, according to a Kantar Health analysis. Such treatment ... Read more

October 19, 2020October 19, 2020

Signatera Test for Residual Disease Will Be Used in New Phase 2 Breast Cancer Trial

News

Signatera, Natera’s personalized test to detect residual signs of cancer in people with solid tumors, will be used in an upcoming Phase 2 trial as a tool to identify patients with ... Read more

October 15, 2020October 15, 2020

Trodelvy Shows Superiority to Chemo for Advanced TNBC in Phase 3 Trial

News

Trodelvy (sacituzumab govitecan), compared with standard chemotherapy, significantly prolonged overall survival and improved the overall response rate of patients with metastatic triple-negative breast cancer (mTNBC) who had at least two prior ... Read more

October 12, 2020October 12, 2020

MammaCare Foundation Offers Simulator Training for Manual Breast Exams

News

The MammaCare Foundation is offering a simulator to help train healthcare professionals and students in performing manual breast exams, with the aim of improving an early diagnosis of breast cancer. Diagnosing breast ... Read more

October 8, 2020October 8, 2020

FDA Puts Eganelisib on Fast Track for Advanced Triple-negative Breast Cancer

News

The U.S. Food and Drug Administration has granted fast track status to immuno-oncology candidate eganelisib (IPI-549) in combination with a checkpoint inhibitor and chemotherapy as a first-line treatment for patients with ... Read more

October 1, 2020October 1, 2020

Activities Abound for Breast Cancer Awareness Month

News

October is Breast Cancer Awareness Month, set aside annually to bring attention to the disorder and the community’s needs. From sharing photographs and educational resources, to hosting virtual fundraisers and wearing ... Read more

September 28, 2020September 28, 2020

Verzenio With Endocrine Therapy Can Lower Risk of Recurrence, Spread in Early Breast Cancer, Trial Shows

News

When given alongside endocrine therapy (ET), Verzenio (abemaciclib) can lower the risk of cancer recurrence and spread compared to standard ET alone in patients with certain forms of early breast cancer ... Read more

September 24, 2020September 24, 2020

Clinical Trial Testing Estrogen Receptor Degrader GDC-9545 Enrolls First Participant

News

The first participant has been enrolled in a Phase 2 clinical trial evaluating the safety and efficacy of GDC-9545 in combination with palbociclib as an investigational treatment for postmenopausal women with estrogen receptor ... Read more

September 21, 2020September 21, 2020

Phase 1 Trial Begins Dosing Patients With Investigational Brain-penetrant HER2 Inhibitor

News

Patient dosing has begun in Zion Pharma‘s Phase 1 clinical trial in the United States to evaluate the safety of its investigational HER2 inhibitor, ZN-A-1041, in people with HER2-positive breast ... Read more